Darrell S Rigel, MD
About Me
Darrell S. Rigel MD MS is Clinical Professor of Dermatology at the Mount Sinai Icahn School of Medicine and is recognized as a world leader in research and patient care in melanoma and other skin cancers. He is a graduate of MIT with a BS in Management Information Sciences, an MS (MBA) from the Sloan School of Management at MIT and received his MD from George Washington University. He attended Cornell University Medical Center for Internship in Internal Medicine and completed his training at NYU where he was Resident, Chief Resident and Dermatology Surgery Fellow and was a National Institutes of Health Training Fellow.
Dr. Rigel has delivered over 1000 presentations at medical and governmental policy conferences worldwide and has chaired numerous national and international conferences and symposia. He co-chairs the Fall and Winter Clinical Dermatology Conferences. He is the author of numerous articles and abstracts in professional journals as well as lead editor of Cancer of the Skin, the major textbook in this field and has testified before Congress and the FDA on related issues. He often appears on National television including CNN, ABC, FOX, NBC and CBS and his research and opinions are regularly cited in the New York Times, Wall Street Journal and many other national magazines and newspapers.
Dr. Rigel serves as the Consultant Dermatologist for the New York Yankees. In addition, Dr. Rigel works with many professional and charitable organizations related to his research interests. He served as President of the American Academy of Dermatology and the American Academy of Dermatology Association and also served for 9 years as a Director of the American Board of Dermatology. He is also a Past President of the American Society for Dermatologic Surgery and the American Dermatological Association and is active in the MIT alumni program serving as a Regional Chair of the MIT Educational Counselor program.
Dr. Rigel has also received numerous awards and honors including the prestigious American Academy of Dermatology’s Gold Medal – the highest award in the specialty in recognition of a lifetime of achievement, the George B. Morgan Award from MIT recognizing exceptional achievement by an alumnus and the Humanitarian Award of the Melanoma Research Foundation. He has also received the American Cancer Society's National Honor Citation for Skin Cancer Programs and multiple Presidential Citations from the Academy and American Society for Dermatologic Surgery for public education programs in skin cancer.
Dr. Rigel enjoys treating and helping improve the lives of patients with melanoma, other skin cancers, pre cancers, sun-damaged skin and high-risk moles.
Language
Position
About Me
Darrell S. Rigel MD MS is Clinical Professor of Dermatology at the Mount Sinai Icahn School of Medicine and is recognized as a world leader in research and patient care in melanoma and other skin cancers. He is a graduate of MIT with a BS in Management Information Sciences, an MS (MBA) from the Sloan School of Management at MIT and received his MD from George Washington University. He attended Cornell University Medical Center for Internship in Internal Medicine and completed his training at NYU where he was Resident, Chief Resident and Dermatology Surgery Fellow and was a National Institutes of Health Training Fellow.
Dr. Rigel has delivered over 1000 presentations at medical and governmental policy conferences worldwide and has chaired numerous national and international conferences and symposia. He co-chairs the Fall and Winter Clinical Dermatology Conferences. He is the author of numerous articles and abstracts in professional journals as well as lead editor of Cancer of the Skin, the major textbook in this field and has testified before Congress and the FDA on related issues. He often appears on National television including CNN, ABC, FOX, NBC and CBS and his research and opinions are regularly cited in the New York Times, Wall Street Journal and many other national magazines and newspapers.
Dr. Rigel serves as the Consultant Dermatologist for the New York Yankees. In addition, Dr. Rigel works with many professional and charitable organizations related to his research interests. He served as President of the American Academy of Dermatology and the American Academy of Dermatology Association and also served for 9 years as a Director of the American Board of Dermatology. He is also a Past President of the American Society for Dermatologic Surgery and the American Dermatological Association and is active in the MIT alumni program serving as a Regional Chair of the MIT Educational Counselor program.
Dr. Rigel has also received numerous awards and honors including the prestigious American Academy of Dermatology’s Gold Medal – the highest award in the specialty in recognition of a lifetime of achievement, the George B. Morgan Award from MIT recognizing exceptional achievement by an alumnus and the Humanitarian Award of the Melanoma Research Foundation. He has also received the American Cancer Society's National Honor Citation for Skin Cancer Programs and multiple Presidential Citations from the Academy and American Society for Dermatologic Surgery for public education programs in skin cancer.
Dr. Rigel enjoys treating and helping improve the lives of patients with melanoma, other skin cancers, pre cancers, sun-damaged skin and high-risk moles.
Language
Position
Clinical Focus
- Actinic Keratosis
- Basal Cell Carcinoma
- Cryotherapy
- Dermoscopy
- Dysplastic Nevi
- Dysplastic Nevus
- Freezing of Warts
- Melanoma
- Mole Removal
Show More
Education
MD, George Washington University
Internship, NY Hospital - Cornell
Residency, New York University
Fellowship, New York University
Publications
Selected Publications
- The association between dermatologist density and melanoma prognosis using melanoma mortality-incidence ratio. Joshua Burshtein, Milaan Shah, Danny Zakria, Darrell Rigel. Melanoma Research
- Clinical Utility of a Digital Dermoscopy Image-Based Artificial Intelligence Device in the Diagnosis and Management of Skin Cancer by Dermatologists. Alexander M. Witkowski, Joshua Burshtein, Michael Christopher, Clay Cockerell, Lilia Correa, David Cotter, Darrell L. Ellis, Aaron S. Farberg, Jane M. Grant-Kels, Teri M. Greiling, James M. Grichnik, Sancy A. Leachman, Anthony Linfante, Ashfaq Marghoob, Etan Marks, Khoa Nguyen, Alex G. Ortega-Loayza, Gyorgy Paragh, Giovanni Pellacani, Harold Rabinovitz, Darrell Rigel, Daniel M. Siegel, Eingun James Song, David Swanson, David Trask, Joanna Ludzik. Cancers
- Advances in Technology for Melanoma Diagnosis and Prognosis: An Expert Consensus Panel. Joshua Burshtein, Danny Zakria, Milaan Shah, Brian Berman, Seemal R. Desai, Aaron S. Farberg, Gary Goldenberg, Brad Glick, Mark Nestor, Keyvan Nouri, Theodore Rosen, Mark Lebwohl, Darrell Rigel. Journal of Drugs in Dermatology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Rigel has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Rigel has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.